Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
1999-06-29
2009-08-11
Canella, Karen A (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S408000
Reexamination Certificate
active
07572762
ABSTRACT:
Compositions, methods, uses and assemblages for the preferential induction of cell division cycle arrest and/or apoptosis, in a first population of cells compared to a second population of cells employ either: (i) an opioid or opioid-like agent and an NF-κB activating agent, which agents are other than the opioid-like agent trans-U50488 in combination with an NF-κB activating agent selected from etoposide and nocodazole; (ii) a ligand for a sigma receptor, or (iii) an opioid or opioid-like agent wherein the cells of the first population are other than tumor cells.
REFERENCES:
patent: 4795747 (1989-01-01), Latman et al.
patent: 5911970 (1999-06-01), John et al.
patent: 6235791 (2001-05-01), Breliere
patent: 681780 (1993-05-01), None
patent: WO 96/06863 (1996-03-01), None
Abstract of Ferris et al (Life Sciences, 1986, vol. 38, pp. 2329-2337).
Abstract of Itoh et al (Naunyn-Schmiededergs Archives of Pharmacology, 1987, vol. 335, pp. 285-289.
John et al (Journal of Medicinal Chemistry, 1994, vol. 37, pp. 1737-1739.
Eeles et al (In: Breast Cancer, vol. 18, Eds Fentiman and Taylor-Papadimitriou, 1993, p. 63, Table 3.
Brent et al (Biochemical and Biophysical Research Communications, 1996, vol. 219, pp. 219-226.
Abstract of Bigbee (Energy Technology Rev, 1980, pp. 1-8.
Abstrat of Guzzie (Diss Abstr Int [B], 1988, vol. 8, p. 2201.
Abstract of Singh (Recent Adv. Cell. Mol. Biol., World Congress, 1992, vol. 2, pp. 117-122.
Abstract of Kataoka et al (International Journal of Radiation Biology, 1992, vol. 61, pp. 387-392.
ATCC Accession No. HTB-22.
The abstract of Moll et al (Hum Pathol, 1995, vol. 26, pp. 1293-1301).
The abstract of Bours et al (Journal of Cell Biochem, 1995, Suppl 19A, p. 30).
Verma et al (Nature, 1997, vol. 389, pp. 239-242).
Eck et al (Gene-Based Therapy, In: The Pharmacological Basis of Therapeutics, Goodman and Gilman, Ed.s, 1996, pp. 77-101).
Orkin et al (“Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH, 1995).
The abstract of Littman et al (Archives of Internal Medicine, 1951, vol. 87, pp. 707-712).
Abstract of Bruger et al (Virchows Archiv fuer Pathologische Anatomie, 1949, vol. 46, pp. 536-541).
Kleeb et al (LifeSciences, 1996, vol. 60, pp. PL69-PL74).
Grunberg et al (Journal of Clincial Oncology, 1984, vol. 2, pp. 782-787).
Silvey et al (Journal of Clinical Oncology, 1988, vol. 6, pp. 1397-1400).
Vilner et al (The Journal of Neuroscience, 1995, vol. 15, pp. 117-134).
Mach et al (Cancer Research, 1997, vol. 57, pp. 156-161).
DeVita et al, ‘Hodgkin's Disease’ In: Cancer, Principles and Practice of Oncology, DeVita et al, Ed.s, 5th Edition, 1997, pp. 2242-2255.
Brent, P.J. and G.T. Pang, “Sigma Binding Site Ligands Inhibit Cell Proliferation in Mammary and Colon Carcinoma Cell Lines and Melanoma . . . ” Eur. J Pharm., 278:151-160 (1995).
McTavish Niall
Perkins Neil Donald
Samson Jayne
Spruce Barbara Ann
Canella Karen A
Dann Dorfman Herrell & Skillman
Netter Robert C.
Rigaut Kathleen D.
University of Dundee
LandOfFree
Materials and methods relating to the induction of apoptosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Materials and methods relating to the induction of apoptosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods relating to the induction of apoptosis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4089983